Skip to content

The treatment effect of combined glenohumeral and subacromial injection of sodium hyaluronate for partial rotator cuff injury: a single-center, prospective, open-label and randomized controlled clinical study

The treatment effect of combined glenohumeral and subacromial injection of sodium hyaluronate for partial rotator cuff injury: a single-center, prospective, open-label and randomized controlled clinical study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095547
Enrollment
Unknown
Registered
2025-01-08
Start date
2024-12-24
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rotator cuff injury

Interventions

combined injection group:combined glenohumeral and subacromial injection of sodium hyaluronate
subacromial injection group:subacromial injection of sodium hyaluronate

Sponsors

Xi'an Jiaotong University Second Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Age 25-65 years old; 2.The diagnosis is in accordance with the diagnostic criteria for partial rotator cuff injury in Practical Osteology (Fourth edition), that is, the MRI examination of shoulder joint showed partial injury, the local flacy-like, linear and irregular signal increase shadow of the rotator cuff was less than 1cm; 3.The patients voluntarily accept the clinical study and signs the informed consent;

Exclusion criteria

Exclusion criteria: 1.Full tear of rotator cuff; 2.Shoulder joint pain caused by other causes (such as frozen shoulder, calcifying tendinitis, rheumatic diseases, cervical spondylosis); 3.History of local injection in the affected shoulder in the past three months; 4.Coagulation disorders; 5.Previous history of shoulder trauma or surgery; 6.Patients that are allergic to sodium hyaluronate or corticosteroids; 7.Infection of the shoulder skin or soft tissue on the affected side; 8.Cognitive dysfunction or mental disorders; 9.Patients that have participated in other clinical investigators within 6 months;

Design outcomes

Primary

MeasureTime frame
VAS score;

Secondary

MeasureTime frame
Shoulder range of motion;Constant-Murley score;UCLASS score;Adverse reaction rate;

Countries

China

Contacts

Public ContactRui Ma

Xi'an Jiaotong University Second Affiliated Hospital

shandongmarui@126.com+86 29 87679869

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026